ARID1A expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 2.10731432304101E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.79060000347209E-08 |
Normal-vs-Stage2 |
6.60869999835612E-08 |
Normal-vs-Stage3 |
2.02404759619412E-12 |
Normal-vs-Stage4 |
9.35389543599285E-11 |
Stage1-vs-Stage2 |
7.148100E-02 |
Stage1-vs-Stage3 |
2.319000E-03 |
Stage1-vs-Stage4 |
3.001200E-03 |
Stage2-vs-Stage3 |
6.661000E-01 |
Stage2-vs-Stage4 |
5.014000E-01 |
Stage3-vs-Stage4 |
7.204800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.00282021470366E-12 |
Normal-vs-AfricanAmerican |
5.75459999985206E-07 |
Normal-vs-Asian |
8.325200E-01 |
Caucasian-vs-AfricanAmerican |
4.962600E-01 |
Caucasian-vs-Asian |
2.030200E-02 |
AfricanAmerican-vs-Asian |
4.085700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.65352192943647E-12 |
Normal-vs-Female |
3.72419994842943E-09 |
Male-vs-Female |
2.709800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.799700E-04 |
Normal-vs-Age(41-60Yrs) |
1.32770000549343E-08 |
Normal-vs-Age(61-80Yrs) |
3.16724424465065E-12 |
Normal-vs-Age(81-100Yrs) |
8.49489999454889E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.376800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.096600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.947900E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.069900E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.276800E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.242100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.158600E-01 |
Normal-vs-Grade 2 |
1.04389999977528E-07 |
Normal-vs-Grade 3 |
1.63291602461868E-12 |
Normal-vs-Grade 4 |
1.74000003294594E-09 |
Grade 1-vs-Grade 2 |
1.722130E-02 |
Grade 1-vs-Grade 3 |
1.203220E-04 |
Grade 1-vs-Grade 4 |
9.825400E-04 |
Grade 2-vs-Grade 3 |
6.169100E-04 |
Grade 2-vs-Grade 4 |
1.218270E-02 |
Grade 3-vs-Grade 4 |
8.793600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
8.17919998397088E-09 |
Normal-vs-ccB subtype |
2.33279995320856E-09 |
ccA subtype-vs-ccB subtype |
1.341170E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.53159723687213E-11 |
Normal-vs-N1 |
1.000480E-03 |
N0-vs-N1 |
7.413600E-01 |
|
|